These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 28874145)

  • 1. Propensity score analysis of lung cancer risk in a population with high prevalence of non-smoking related lung cancer.
    Lin KF; Wu HF; Huang WC; Tang PL; Wu MT; Wu FZ
    BMC Pulm Med; 2017 Sep; 17(1):120. PubMed ID: 28874145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of Selection Criteria for Low-Dose Lung Screening CT Among Asian Ethnic Groups in Taiwan: From Mass Screening to Specific Risk-Based Screening for Non-Smoker Lung Cancer.
    Wu FZ; Huang YL; Wu CC; Tang EK; Chen CS; Mar GY; Yen Y; Wu MT
    Clin Lung Cancer; 2016 Sep; 17(5):e45-e56. PubMed ID: 27133540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lung cancer screening with low-dose computed tomography: Experiences from a tertiary hospital in Taiwan.
    Chen CY; Chen CH; Shen TC; Cheng WC; Hsu CN; Liao CH; Chen CY; Hsia TC; Liao WC; Tu CY; Shih CM; Hsu WH
    J Formos Med Assoc; 2016 Mar; 115(3):163-70. PubMed ID: 26714425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung cancer screening with low dose CT: experience at Campus Bio-Medico of Rome on 1500 patients.
    Crucitti P; Gallo IF; Santoro G; Mangiameli G
    Minerva Chir; 2015 Dec; 70(6):393-9. PubMed ID: 25700151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modified Lung-RADS Improves Performance of Screening LDCT in a Population with High Prevalence of Non-smoking-related Lung Cancer.
    Hsu HT; Tang EK; Wu MT; Wu CC; Liang CH; Chen CS; Mar GY; Lai RS; Wang JC; Wu CL; Huang YL; Wu FZ
    Acad Radiol; 2018 Oct; 25(10):1240-1251. PubMed ID: 29530488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Occurrence and lung cancer probability of new solid nodules at incidence screening with low-dose CT: analysis of data from the randomised, controlled NELSON trial.
    Walter JE; Heuvelmans MA; de Jong PA; Vliegenthart R; van Ooijen PMA; Peters RB; Ten Haaf K; Yousaf-Khan U; van der Aalst CM; de Bock GH; Mali W; Groen HJM; de Koning HJ; Oudkerk M
    Lancet Oncol; 2016 Jul; 17(7):907-916. PubMed ID: 27283862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublobar resection is equivalent to lobectomy for clinical stage 1A lung cancer in solid nodules.
    Altorki NK; Yip R; Hanaoka T; Bauer T; Aye R; Kohman L; Sheppard B; Thurer R; Andaz S; Smith M; Mayfield W; Grannis F; Korst R; Pass H; Straznicka M; Flores R; Henschke CI;
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):754-62; Discussion 762-4. PubMed ID: 24280722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung cancer screening using low-dose computed tomography in at-risk individuals: the Toronto experience.
    Menezes RJ; Roberts HC; Paul NS; McGregor M; Chung TB; Patsios D; Weisbrod G; Herman S; Pereira A; McGregor A; Dong Z; Sitartchouk I; Boerner S; Tsao MS; Keshavjee S; Shepherd FA
    Lung Cancer; 2010 Feb; 67(2):177-83. PubMed ID: 19427055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of implementing computed tomography screening for lung cancer in Taiwan.
    Yang SC; Lai WW; Lin CC; Su WC; Ku LJ; Hwang JS; Wang JD
    Lung Cancer; 2017 Jun; 108():183-191. PubMed ID: 28625633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lung cancer screening: fourteen year experience of the Pamplona early detection program (P-IELCAP).
    Sanchez-Salcedo P; Berto J; de-Torres JP; Campo A; Alcaide AB; Bastarrika G; Pueyo JC; Villanueva A; Echeveste JI; Lozano MD; García-Velloso MJ; Seijo LM; García J; Torre W; Pajares MJ; Pío R; Montuenga LM; Zulueta JJ
    Arch Bronconeumol; 2015 Apr; 51(4):169-76. PubMed ID: 25641356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracoronary Thoracic and Coronary Artery Calcifications on Chest CT for Lung Cancer Screening: Association with Established Cardiovascular Risk Factors - The "CT-Risk" Trial.
    Dirrichs T; Penzkofer T; Reinartz SD; Kraus T; Mahnken AH; Kuhl CK
    Acad Radiol; 2015 Jul; 22(7):880-9. PubMed ID: 25957500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Lung Cancer Occurrence in Never-Smoking Females in Asia: TNSF-SQ, a Prediction Model.
    Chien LH; Chen CH; Chen TY; Chang GC; Tsai YH; Hsiao CF; Chen KY; Su WC; Wang WC; Huang MS; Chen YM; Chen CY; Liang SK; Chen CY; Wang CL; Lee MH; Chung RH; Tsai FY; Hu JW; Katki HA; Chatterjee N; Chanock SJ; Rothman N; Lan Q; Yang PC; Chen CJ; Chang IS; Hsiung CA
    Cancer Epidemiol Biomarkers Prev; 2020 Feb; 29(2):452-459. PubMed ID: 31848206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening.
    Horeweg N; van Rosmalen J; Heuvelmans MA; van der Aalst CM; Vliegenthart R; Scholten ET; ten Haaf K; Nackaerts K; Lammers JW; Weenink C; Groen HJ; van Ooijen P; de Jong PA; de Bock GH; Mali W; de Koning HJ; Oudkerk M
    Lancet Oncol; 2014 Nov; 15(12):1332-41. PubMed ID: 25282285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Risk factors for the development of lung cancer in a cohort of adult smokers].
    Saldías Peñafiel F; Elola Aránguiz JM; Uribe Monasterio J; Morales Soto A; Díaz Patiño O
    Rev Med Chil; 2016 Nov; 144(11):1382-1390. PubMed ID: 28394954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT.
    Lopes Pegna A; Picozzi G; Mascalchi M; Maria Carozzi F; Carrozzi L; Comin C; Spinelli C; Falaschi F; Grazzini M; Innocenti F; Ronchi C; Paci E;
    Lung Cancer; 2009 Apr; 64(1):34-40. PubMed ID: 18723240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The BUILT study: a single-center 5-year experience of Lung Cancer screening in Taiwan.
    Wu CW; Ku YT; Huang CY; Hsieh PC; Lim KE; Tzeng IS; Lan CC; Wu YK; Hsu YC
    Int J Med Sci; 2021; 18(16):3861-3869. PubMed ID: 34790062
    [No Abstract]   [Full Text] [Related]  

  • 17. Having found the unexpected, we should look again: in favor of lung cancer screening.
    Kolade VO; Bosu DR
    Tenn Med; 2014 Feb; 107(2):37-8. PubMed ID: 24592691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of indeterminate pulmonary nodules detected in lung cancer screening: Diagnostic accuracy of FDG PET/CT.
    Garcia-Velloso MJ; Bastarrika G; de-Torres JP; Lozano MD; Sanchez-Salcedo P; Sancho L; Nuñez-Cordoba JM; Campo A; Alcaide AB; Torre W; Richter JA; Zulueta JJ
    Lung Cancer; 2016 Jul; 97():81-6. PubMed ID: 27237032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of low-dose spiral computed tomography in lung cancer screening].
    Zhang Y; Hong QY; Shi WB; Ou JX; Yang DW; Hu J; Bai CX; Zeng MS; Chen G
    Zhonghua Yi Xue Za Zhi; 2013 Oct; 93(38):3011-4. PubMed ID: 24417917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for primary lung cancer among never smokers by gender in a matched case-control study.
    Lo YL; Hsiao CF; Chang GC; Tsai YH; Huang MS; Su WC; Chen YM; Hsin CW; Chang CH; Yang PC; Chen CJ; Hsiung CA
    Cancer Causes Control; 2013 Mar; 24(3):567-76. PubMed ID: 22729933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.